{"id":"https://openalex.org/W2113869052","doi":null,"title":"Dual Targeting of Angiopoietin-2 and VEGF Signaling for the Treatment of Glioblastoma","display_name":"Dual Targeting of Angiopoietin-2 and VEGF Signaling for the Treatment of Glioblastoma","alternate_titles":[],"publication_year":2015,"publication_date":"2015-01-29","ids":{"openalex":"https://openalex.org/W2113869052","mag":"2113869052"},"language":"en","primary_location":{"id":"pmh:oai:dash.harvard.edu:1/14226044","doi":null,"is_oa":false,"landing_page_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:14226044","pdf_url":null,"source":{"id":"https://openalex.org/S4306401540","display_name":"Digital Access to Scholarship at Harvard (DASH) (Harvard University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I136199984","host_organization_name":"Harvard University","host_organization_lineage":["https://openalex.org/I136199984"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Thesis or Dissertation"},"parent_works":[],"lineage":["https://openalex.org/W2113869052"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010807520","display_name":"Teresa E. Peterson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Teresa Peterson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5010807520"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":1.0},{"id":"https://openalex.org/keywords/angiopoietin-2","display_name":"angiopoietin-2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/vegf-signaling","display_name":"VEGF signaling","score":0.9860000014305115},{"id":"https://openalex.org/keywords/vegfr-inhibition","display_name":"VEGFR inhibition","score":0.7179999947547913},{"id":"https://openalex.org/keywords/cediranib","display_name":"cediranib","score":0.8960000276565552},{"id":"https://openalex.org/keywords/vessel-normalization","display_name":"vessel normalization","score":0.7789999842643738},{"id":"https://openalex.org/keywords/vasogenic-edema","display_name":"vasogenic edema","score":0.8420000076293945},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.8769999742507935},{"id":"https://openalex.org/keywords/csf-1-receptor","display_name":"CSF-1 receptor","score":0.6710000038146973},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8349999785423279},{"id":"https://openalex.org/keywords/orthotopic-tumor-model","display_name":"orthotopic tumor model","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.7822258472442627},{"id":"https://openalex.org/C2909146873","wikidata":"https://www.wikidata.org/wiki/Q14912185","display_name":"Angiopoietin 2","level":4,"score":0.7708841562271118},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.5846912860870361},{"id":"https://openalex.org/C2779094623","wikidata":"https://www.wikidata.org/wiki/Q539710","display_name":"Angiopoietin","level":4,"score":0.5763919949531555},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4953838586807251},{"id":"https://openalex.org/C2780980858","wikidata":"https://www.wikidata.org/wiki/Q110022","display_name":"Dual (grammatical number)","level":2,"score":0.46653205156326294},{"id":"https://openalex.org/C85219853","wikidata":"https://www.wikidata.org/wiki/Q4763284","display_name":"Angiopoietin receptor","level":3,"score":0.442402184009552},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33251529932022095},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.32036536931991577},{"id":"https://openalex.org/C142362112","wikidata":"https://www.wikidata.org/wiki/Q735","display_name":"Art","level":0,"score":0.0587327778339386},{"id":"https://openalex.org/C124952713","wikidata":"https://www.wikidata.org/wiki/Q8242","display_name":"Literature","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:dash.harvard.edu:1/14226044","doi":null,"is_oa":false,"landing_page_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:14226044","pdf_url":null,"source":{"id":"https://openalex.org/S4306401540","display_name":"Digital Access to Scholarship at Harvard (DASH) (Harvard University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I136199984","host_organization_name":"Harvard University","host_organization_lineage":["https://openalex.org/I136199984"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Thesis or Dissertation"},{"id":"mag:2113869052","doi":null,"is_oa":false,"landing_page_url":"https://dash.harvard.edu/handle/1/14226044","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2587171270","https://openalex.org/W2328171087","https://openalex.org/W2488801043","https://openalex.org/W7018429752","https://openalex.org/W2166215138","https://openalex.org/W2495850459","https://openalex.org/W2326749252","https://openalex.org/W2261205543","https://openalex.org/W2586490694","https://openalex.org/W2588994663"],"abstract_inverted_index":{"Glioblastoma":[0],"(GBM)":[1],"is":[2,14],"the":[3,17,28,65,78,109,169,206,256,267,283,303,311],"most":[4],"common":[5],"and":[6,53,87,116,127,157,172,180,194,247,307],"aggressive":[7],"brain":[8],"tumor":[9,192,201,234,261],"in":[10,70,85,99,122,150,163,190,205,255],"humans.":[11],"Because":[12],"GBM":[13,100,155,306],"highly":[15],"angiogenic,":[16],"anti-vascular":[18],"endothelial":[19],"growth":[20,179],"factor":[21],"(VEGF)":[22],"antibody":[23,281],"bevacizumab":[24],"has":[25,227],"now":[26],"become":[27,40],"standard":[29,43],"of":[30,34,56,64,75,80,92,114,125,134,154,168,173,258,271,286,305,310,313],"care":[31],"for":[32,61,302],"treatment":[33,84,304],"recurrent":[35],"GBM.":[36,71],"However,":[37],"GBMs":[38],"rapidly":[39],"refractory":[41],"to":[42,196,230,236,266],"anti-VEGF":[44,81],"therapy.":[45,289],"It":[46],"was":[47,148,215,250],"previously":[48],"demonstrated":[49],"that":[50,89,111,167,204],"vessel":[51,241],"normalization":[52,224,242],"subsequent":[54],"reduction":[55],"intracranial":[57],"vasogenic":[58],"edema":[59,220],"accounts":[60],"a":[62,136,197,298],"majority":[63],"benefit":[66,285],"from":[67,244],"inhibiting":[68],"VEGF-signaling":[69],"Also,":[72],"ectopic":[73],"over-expression":[74],"Ang-2":[76,93,117,246],"compromises":[77],"benefits":[79],"receptor":[82],"(VEGFR)":[83],"mice":[86],"showed":[88],"circulating":[90],"levels":[91],"rebound":[94],"after":[95],"an":[96,144,232,237,253,275],"initial":[97],"decrease":[98],"patients":[101],"treated":[102,208],"with":[103,142,209,225,252,274],"anti-VEGFR":[104],"agents.":[105],"This":[106],"thesis":[107],"examines":[108],"hypothesis":[110],"combined":[112,141,245],"inhibition":[113,249],"VEGF":[115],"signaling":[118],"can":[119],"improve":[120],"survival":[121,162,284],"murine":[123],"models":[124,153,165,193],"GBM,":[126],"investigates":[128],"potential":[129,299],"underlying":[130],"mechanisms.":[131],"The":[132,290],"efficacy":[133],"cediranib,":[135],"pan-VEGFR":[137],"tyrosine":[138],"kinase":[139],"inhibitor,":[140],"MEDI3617,":[143],"anti-Ang-2":[145],"neutralizing":[146,280],"antibody,":[147],"tested":[149],"two":[151],"orthotopic":[152],"(U87":[156],"Gl261).":[158],"Combination":[159,184],"therapy":[160,185,214],"improved":[161],"both":[164,191],"beyond":[166],"monotherapy":[170],"arms":[171],"control":[174],"IgG":[175],"by":[176],"delaying":[177],"Gl261":[178],"increasing":[181],"U87":[182],"necrosis.":[183],"increased":[186],"perivascular":[187],"cell":[188],"coverage":[189],"led":[195],"more":[198],"mature,":[199],"normalized":[200],"vasculature":[202],"than":[203],"tumors":[207],"cediranib":[210],"alone.":[211],"Importantly,":[212],"combination":[213,288],"as":[216,221],"effective":[217],"at":[218],"controlling":[219],"cediranib.":[222],"Vascular":[223],"VEGF-blockade":[226],"been":[228],"shown":[229],"convert":[231],"immunoinhibitory":[233],"microenvironment":[235],"immunostimulatory":[238],"one.":[239],"Improved":[240],"resulting":[243],"VEGFR":[248],"associated":[251,262],"increase":[254],"number":[257],"M1-like":[259],"(anti-tumor)":[260],"macrophages":[263],"(TAMs)":[264],"compared":[265],"cediranib-treated":[268],"tumors.":[269],"Inhibition":[270],"TAM":[272],"recruitment":[273],"anti-colony":[276],"stimulating":[277],"factor-1":[278],"(CSF1)":[279],"compromised":[282],"anti-Ang-2/VEGFR":[287],"work":[291],"described":[292],"here":[293],"provides":[294],"new":[295],"insight":[296],"into":[297],"therapeutic":[300,318],"strategy":[301],"should":[308],"inform":[309],"design":[312],"clinical":[314],"trials":[315],"on":[316],"this":[317],"combination.":[319]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2113869052","counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
